Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,548,597 papers from all fields of science
Search
Sign In
Create Free Account
Brivaracetam
Known as:
(2S)-2-((4R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide
, 1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-
, 2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Broader (2)
Anticonvulsants
Pyrrolidinones
Brivaracetam 10 MG Oral Tablet [Briviact]
Brivaracetam 25 MG Oral Tablet
Epoxide Hydrolase Inhibitors [MoA]
Narrower (2)
Briviact
UCB 34714
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
New anti-epileptic drugs in paediatrics
Ignacio Málaga
,
R. Sánchez-Carpintero
,
S. Roldán
,
J. Ramos-Lizana
,
J. García-Peñas
Anales de Pediatría (English Edition)
2019
Corpus ID: 214139975
2018
2018
Exceptional response to brivaracetam in a patient with refractory idiopathic generalized epilepsy and absence seizures.
A. Grande-Martín
,
D. Sopelana-Garay
,
J. Pardal-Fernández
,
R. Sánchez-Honrubia
,
Á. Sánchez-Larsen
Epileptic disorders
2018
Corpus ID: 3430625
Brivaracetam is currently indicated as adjunctive therapy for patients with focal-onset seizures with or without secondary…
Expand
2017
2017
Anger Assessment in Patients Treated With Brivaracetam
G. Ortega
,
L. Abraira
,
+5 authors
M. Toledo
Clinical neuropharmacology
2017
Corpus ID: 24630761
Objectives To assess state and trait anger, adjusted by epilepsy type, seizure control, anxiety-depression status and quality of…
Expand
Review
2017
Review
2017
Will Brivaracetam Help My Patient? Only Time Will Tell
J. French
Epilepsy Currents
2017
Corpus ID: 46615216
Commentary Brivaracetam (BRV) is the latest antiepileptic drug to reach the marketplace, and many clinicians are contemplating…
Expand
Review
2016
Review
2016
Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base
C. Brandt
,
T. May
,
C. Bien
Therapeutic Advances in Neurological Disorders
2016
Corpus ID: 41746694
Brivaracetam (BRV) is a novel antiepileptic drug recently licensed for the treatment of partial epilepsy in adults and…
Expand
Review
2014
Review
2014
Brivaracetam for the treatment of epilepsy in adults
M. Mula
Expert Review of Neurotherapeutics
2014
Corpus ID: 31809941
Brivaracetam (BRV) is a new antiepileptic drug structurally related to levetiracetam but with a 15 to 30-fold increased affinity…
Expand
2014
2014
Brivaracetam, a Novel Antiepileptic Drug: Is it Effective and Safe? Results from One Phase III Randomized Trial
A. Pack
Epilepsy Currents
2014
Corpus ID: 35476044
Commentary Despite the availability of multiple AEDs, many patients with epilepsy continue to have refractory seizures as well as…
Expand
Review
2010
Review
2010
New drugs for pediatric epilepsy.
C. Chu-Shore
,
E. Thiele
Seminars in Pediatric Neurology
2010
Corpus ID: 24760542
Review
2006
Review
2006
New antiepileptic drugs that are second generation to existing antiepileptic drugs
M. Bialer
Expert Opinion on Investigational Drugs
2006
Corpus ID: 21166138
In the last decade, 10 new antiepileptic drugs (AEDs) have been introduced that offer appreciable advantages in terms of their…
Expand
2005
2005
Antiepileptic drug discovery: lessons from the past and future challenges
H. Klitgaard
Acta Neurologica Scandinavica, Supplementum
2005
Corpus ID: 2953293
Historically, most antiepileptic drugs (AEDs) have been discovered either by serendipity, or the screening of compounds using…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE